| Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study (NCT05106608) | Universidad de Granada | 2022-07-13 |
| Accuracy and Safety of Coplanar Template Assistance for Head and Neck Biopsies. (NCT05396183) | Peking University Third Hospital | 2022-05-25 |
| Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. (NCT05341206) | Chang Gung Memorial Hospital | 2022-04-15 |
| Prospective Evaluation of ENDOSWIR Device Versus Pathology for Squamous Cell Carcinoma of Upper Aerodigestive Tract (ENDOSWIR-VADS) (NCT05318872) | University Hospital, Grenoble | 2022-04-11 |
| Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy (NCT06910566) | Centre Oscar Lambret | 2022-03-28 |
| Collection of Head Images During Radiotherapy (NCT05218824) | University of Sydney | 2022-02-14 |
| Prehabilitation and Recovery After Head and Neck Cancer Surgery (NCT04598087) | University of Calgary | 2022-02-09 |
| Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN (NCT05260671) | Eye & ENT Hospital of Fudan University | 2022-01-25 |
| Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution (NCT04782726) | The University of Texas Health Science Center at San Antonio | 2021-12-16 |
| Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy (NCT05022667) | University of Michigan | 2021-12-01 |
| Ideal Drainage Output of Post-operative Neck Suction Drain (NCT03971760) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-11-01 |
| The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas (NCT05187091) | All India Institute of Medical Sciences | 2021-07-12 |
| Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies (NCT04878692) | Hospices Civils de Lyon | 2021-06-01 |
| Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial (NCT05418842) | Associacao de Investigacao de Cuidados de Suporte em Oncologia | 2021-05-28 |
| Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy (NCT05308732) | Instituto Nacional de Cancer, Brazil | 2021-05-11 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer (NCT04634825) | MacroGenics | 2021-03-17 |
| The EMINENCE Study - PET/MR Imaging of Head Neck Cancer (NCT04612075) | Norwegian University of Science and Technology | 2021-01-12 |
| External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC (NCT04697446) | Blueprint Medicines Corporation | 2020-12-01 |
| Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest (NCT03875833) | The University of Texas Health Science Center, Houston | 2020-10-09 |
| A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck (NCT04435938) | McMaster University | 2020-09-10 |
| Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT (NCT05068687) | University Hospital, Ghent | 2020-08-28 |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972) | Hoffmann-La Roche | 2020-07-24 |
| Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery (NCT04420689) | Alume Biosciences, Inc. | 2020-06-18 |
| Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection (NCT04247282) | National Cancer Institute (NCI) | 2020-06-09 |
| Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors (NCT04429542) | Bicara Therapeutics | 2020-06-01 |
| A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer (NCT04405154) | West China Hospital | 2020-06-01 |
| Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery (NCT04266015) | E-DA Hospital | 2020-04-16 |
| Epigenetic Changes in Head and Neck Cancer (NCT04260074) | Aalborg University Hospital | 2020-03-11 |
| The Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Head and Neck Cancer (NCT04208334) | Phramongkutklao College of Medicine and Hospital | 2020-02-13 |
| Regional Anesthesia Block in Fibula Free Flap Reconstruction (NCT03906838) | University of Florida | 2020-01-01 |
| HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer (NCT04188951) | Henry Ford Health System | 2019-10-04 |
| DAHANCA 37. Re-irradiation With Proton Radiotherapy (NCT03981068) | Danish Head and Neck Cancer Group | 2019-09-01 |
| Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT (NCT04996147) | Associacao de Investigacao de Cuidados de Suporte em Oncologia | 2019-06-01 |
| The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) (NCT03914378) | University of Manchester | 2019-05-01 |
| Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck (NCT03818061) | Centre Leon Berard | 2019-03-26 |
| Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma (NCT03799744) | Institut Català d'Oncologia | 2019-03-20 |
| Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198) | Christian von Buchwald | 2019-03-01 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) (NCT03695510) | National Taiwan University Hospital | 2019-01-24 |
| This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 (NCT03780725) | Boehringer Ingelheim | 2019-01-22 |
| Head and Neck Cancer in Children: A Retrospective Study (NCT02557048) | Assiut University | 2019-01-10 |
| Rehabilitation Planning Consult Phase II Trial (NCT03672799) | University Health Network, Toronto | 2019-01-07 |
| Unilateral Neck Radiotherapy in Head and Neck Cancer (NCT03622164) | AHS Cancer Control Alberta | 2018-12-21 |
| Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) (NCT03765918) | Merck Sharp & Dohme LLC | 2018-12-17 |
| Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction (NCT03549494) | Catalysis SL | 2018-10-25 |
| Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03691714) | Trisha Wise-Draper | 2018-10-23 |
| H&N Cancer; Survivorship and Late Effects (NCT04758026) | Oslo University Hospital | 2018-10-10 |
| A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC (NCT03678649) | Zhejiang Cancer Hospital | 2018-09-10 |
| EMST and Swallowing in Long-Term Survivors of HNCA (NCT03975465) | University of Wisconsin, Milwaukee | 2018-09-10 |
| Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) (NCT03515824) | Merck Sharp & Dohme LLC | 2018-08-13 |
| Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment (NCT03547388) | Charite University, Berlin, Germany | 2018-07-01 |
| Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager (NCT03561324) | University of Arkansas | 2018-06-20 |
| Needs Assessment Tool Integrated in Clinical Practice of Head and Neck Cancer Rehabilitation (NCT03443258) | Rigshospitalet, Denmark | 2018-06-11 |
| Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers (NCT03546322) | University of California, San Francisco | 2018-06-01 |
| Biospecimen Procurement for Head and Neck Disorders (NCT03429036) | National Cancer Institute (NCI) | 2018-05-23 |
| Radiotherapy Treatments for Neoplasms in the Head and Neck Region (NCT06335342) | European Institute of Oncology | 2018-02-22 |
| STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03 (NCT03401840) | Centre Jean Perrin | 2018-01-23 |
| A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment (NCT03332160) | Tactile Medical | 2018-01-02 |
| Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer (NCT03051906) | Azienda Ospedaliero-Universitaria Careggi | 2018-01-01 |
| Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation (NCT03225157) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2017-11-03 |
| A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based Therapy (NCT03356587) | Seoul National University Hospital | 2017-10-16 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer (NCT05269342) | YU LONG HONG | 2017-09-14 |
| PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning (NCT03286972) | University of Wisconsin, Madison | 2017-09-12 |
| Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] (NCT03292250) | Seoul National University Hospital | 2017-09-10 |
| Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma (NCT06446570) | Seoul National University Hospital | 2017-09-10 |
| EPR Tumor Oximetry With CE India Ink (NCT03321903) | Philip Schaner | 2017-08-30 |
| EMST in Patients Undergoing CRT for HNCA (NCT03916809) | University of Wisconsin, Milwaukee | 2017-07-12 |
| A Study of AK-01 (LY3295668) in Solid Tumors (NCT03092934) | Eli Lilly and Company | 2017-05-29 |
| Radiotherapy Related Skin Toxicity: Mepitel® vs. Standard Care in Patients With Locally Advanced Head-and-Neck Cancer (NCT03047174) | University Hospital Schleswig-Holstein | 2017-05-09 |
| To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer (NCT03020823) | SynCore Biotechnology Co., Ltd. | 2017-04-30 |
| Effects of Nutritional Counseling on Nutritional Status and Quality of Life of Head and Neck Cancer Patients (NCT03114202) | University of Sao Paulo General Hospital | 2017-04-18 |
| Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412) (NCT03040999) | Merck Sharp & Dohme LLC | 2017-04-05 |
| Exercise After Radiation for Head & Neck Cancer (NCT04013178) | University of Calgary | 2017-03-31 |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03082534) | University of California, San Diego | 2017-03-28 |
| Outpatient Percutaneous Radiologic Gastrostomy in Patients With Head and Neck Tumors (NCT03252509) | Instituto Nacional de Cancer, Brazil | 2017-03-20 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| Gastric Pull up Versus Free Flap Reconstruction for Laryngo-pharyngeal Defects (NCT03171558) | University of British Columbia | 2017-03-16 |
| Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer (NCT02216669) | Maastricht Radiation Oncology | 2017-03-01 |
| ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (NCT03003637) | The Netherlands Cancer Institute | 2017-02-28 |
| Cell-free Tumor DNA in Head and Neck Cancer Patients (NCT03942380) | Christian von Buchwald | 2017-02-01 |
| Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection (NCT02918955) | Insel Gruppe AG, University Hospital Bern | 2016-12-16 |
| P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC (NCT03077243) | UNC Lineberger Comprehensive Cancer Center | 2016-12-01 |
| Apatinib for Advanced Non-squamous Head and Neck Cancer (NCT02989259) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2016-12-01 |
| uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer (NCT02960724) | Rigshospitalet, Denmark | 2016-11-01 |
| The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer (NCT02943252) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2016-10-01 |
| Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema (NCT02946021) | Tactile Medical | 2016-10-01 |
| Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors (NCT02975739) | UMC Utrecht | 2016-09-01 |
| Pharmacotherapy Personalization of Cancer Patients (NCT04866498) | Poznan University of Medical Sciences | 2016-07-01 |
| Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer (NCT02817113) | Orient Europharma Co., Ltd. | 2016-06-01 |
| Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity (NCT02442375) | Radboud University Medical Center | 2016-06-01 |
| Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors (NCT02647021) | University of Alberta | 2016-03-31 |
| A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer (NCT02555644) | Eli Lilly and Company | 2016-02-24 |
| Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy (NCT02485470) | University of Michigan Rogel Cancer Center | 2016-02-01 |
| Oncogeriatric Intervention and Follow-up at Home (NCT02837679) | Aarhus University Hospital | 2016-01-01 |
| Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer (NCT02836769) | Sunnybrook Health Sciences Centre | 2016-01-01 |
| Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN ) (NCT02633800) | Daiichi Sankyo | 2015-12-22 |
| Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02643550) | Innate Pharma | 2015-12-01 |
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (NCT02568267) | Hoffmann-La Roche | 2015-11-19 |